Kedrion Announces Rare Disease Medicine RYPLAZIM® Now Available in the United States
Apr 29, 2024 |
Distribution resumes of first and only medicine to treatplasminogen deficiency type 1
Kedrion Presents Advancements in Ultra-Rare Bleeding Disorders Research
Apr 24, 2024 |
At World Federation of Hemophilia Congress
Kedrion Biopharma Marks Fourth Annual Hereditary Factor 10 Deficiency Day on October 10
Oct 10, 2023 |
Global biopharma company encourages education and awareness around a rare bleeding disorder.
Kedrion stands with the Immunodeficiency community
Sep 11, 2023 |
Our support for patients’ associations worldwide with the objective of improving the life of individuals affected by PIDs